MAVENIR
Mavenir, the Network Software Provider building the future of networks with cloud-native software that runs on any cloud and transforms the way the world connects, announced today that it’s working with National Telecom Public Company Limited (NT), a state-owned telecommunications company, 5GCT , a local partner specialized in delivering end-to-end 5G Smart Cities and Cisco Systems (Thailand), a leading networking company, to launch the first 5G Open RAN Smart City in Ban Chang, Thailand.
The launch of the 5G Smart City creates synergies between public and private sectors for a fully functional smart city. The city of Ban Chang, is connected to a motorway linking Thailand’s two largest cities: Pattaya and Bangkok. The location is within close proximity to U-Tapao International Airport, Map Ta Phut Industrial Zone and the new master planned Ban Chang Smart City that are strategically important infrastructure for the Digital Economy in Thailand and the Eastern Economic Corridor (EEC). These characteristics make Ban Chang the perfect city to take advantage of 5G use cases across industrial robots, factory automation, remote telemedicine, aviation, logistics and agriculture. Industry leaders are terming the development the ‘Silicon Beach ’ of Asia.
The Ban Chang Smart City 5G Private Network operates on Millimeter wave (mmWave) spectrum, spectrum which is ideally suited for a network operating Internet of Thing (IoT) sensors, drones and smart poles, all applications which require fast data uplink to the core for realtime analysis and city management.
Mavenir provided a cloud-native, open architecture-based Private Network solution that enabled TOT1 to reach the promise of 5G. The software-based platform enabled the transformation of the mobile communication private network into a completely virtualized environment, where devices, applications, and services run on an automated network using open architecture, containers, and artificial intelligence (AI). Mavenir’s end-to-end 5G Open RAN, Millimeter wave (mmWave) radios and 5G Core with Open API technology standards, in-sync with the cloud-native solutions supporting private On-Premise applications delivers Smart City concepts such as real-time diagnostics of traffic, public safety, digital signage and sensitive environmental conditions.
TOT’s IP transport infrastructure vendor and a key Mavenir technology partner, Cisco, provided switching hardware and application services to enable the ‘smart’ components of the 5G solution.
Mavenir’s Aniruddho Basu, GM of its Emerging Business Unit , said “We are proud to be part of this ambitious 5G project which sees a whole city connected on a series of 5G applications running in parallel. Connectivity is at the heart of this deployment - connecting people, communities, government services, and private sector services through local government data combined with new data acquired through Internet of Things (IOT), sensors, drones, and external collected data, to fully analyze it for proper city management and citizen knowledge.”
Commenting on the announcement, Shannon Kalayanamitr, Chief Executive Officer at 5GCT , said “At 5GTC, we are driven to strengthen the potential of Thailand through high speed 5G. The partnership with Mavenir as an infrastructure provider enables us to deliver robust, secure and reliable 5G Private Network infrastructure across enterprises, including smart city applications, industry 4.0 applications - automated industry and modern medicine.”
Taweewat Chantaraseno, Managing Director, Thailand & Indochina, Cisco Systems (Thailand), said “We are delighted to be part of the first 5G smart city in Thailand. With the partnership with Mavenir and Cisco Connected Communities Infrastructure (CCI), the host of Smart City can create a single, secure communications network to support all needs that are simpler to deploy and manage from end-to-end visibility, ranging from smart kiosks and outdoor Wi-Fi, to smart street lighting, parking, waste and more. Smart city infrastructure is enabling efficiency, cost reduction and improved living for city occupants and network infrastructure platform helps create these efficiencies.
About Mavenir:
Mavenir is building the future of networks and pioneering advanced technology, focusing on the vision of a single, software-based automated network that runs on any cloud. As the industry's only end-to-end, cloud-native network software provider, Mavenir is focused on transforming the way the world connects, accelerating software network transformation for 250+ Communications Service Providers in over 120 countries, which serve more than 50% of the world’s subscribers.
Visit: www.mavenir.com
1 TOT and CAT Telecom recently merged under National Telecommunications Public Company Limited (NT) a Thai Government Telecom service provider
View source version on businesswire.com: https://www.businesswire.com/news/home/20210520005943/en/
Link:
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
CoMotion GLOBAL 2025 Launches in Riyadh: Global Mobility Leaders Unite in Saudi Capital to Chart Urban Future7.12.2025 13:00:00 CET | Press release
Summit debuts Mayors in Motion initiative and CoMotion Urban Visionary Distinction as Riyadh showcases its rise as global mobility testbed Riyadh is rapidly becoming one of the world's most ambitious urban mobility laboratories, where next-generation technologies move from blueprint to real-world deployment on city streets at unprecedented scale. CoMotion GLOBAL 2025, the world's most influential gathering of urban mobility leaders, opens today in Riyadh for a three-day summit bringing together innovators from Africa, Asia, Europe, the Americas, and the Middle East. Running December 7-9, the event will explore how electrification, autonomy, AI-enabled transport, and giga-project urbanism are reshaping cities worldwide. The summit will spotlight everything from high-performance EVs and breakthrough autonomous fleets to emerging-market transport solutions and new mobility models, demonstrating how the Kingdom is opening new pathways for global mobility leadership. Strategic Partnerships
Deciphera Announces Oral Presentation of Positive Topline Results from Phase 2a Study of Sapablursen in Polycythemia Vera at the 67th American Society of Hematology (ASH) Annual Meeting6.12.2025 15:30:00 CET | Press release
Results from Phase 2a IMPRSSION study demonstrate sapablursen significantly reduced phlebotomy rate, controlled hematocrit and increased serum hepcidin Sapablursen was generally safe and well tolerated Results support further development of sapablursen in a Phase 3 study Deciphera Pharmaceuticals, a member of Ono Pharmaceutical Co., Ltd. (Headquarters: Osaka, Japan; President and COO: Toichi Takino; “Ono”), today announced the oral presentation of positive results from the Phase 2a IMPRSSION study of sapablursen in patients with polycythemia vera (PV) at the 67th American Society of Hematology (ASH) Annual Meeting, taking place December 6-9, 2025, in Orlando, FL. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251206361611/en/ The results were presented by Ionis Pharmaceuticals, who discovered and developed sapablursen and conducted the IMPRSSION study. In March 2025, Ionis and Ono entered into a license agreement in which On
Protagonist and Takeda Present Longer-Term Data at ASH 2025 Showing Rusfertide Delivers Durable Response and Hematocrit Control in Polycythemia Vera6.12.2025 15:30:00 CET | Press release
52-Week Results from the Phase 3 VERIFY Study of Rusfertide Demonstrated Sustained Hematocrit Control and Response, Defined by Absence of Phlebotomy Eligibility, with No New Safety SignalsThese Data Build on Positive 32-Week Primary Analysis from VERIFY, Which Met its Primary Efficacy Endpoint and All Four Key Secondary EndpointsPatients Crossing Over from Placebo to Rusfertide at 32 Weeks Achieved a Similar Response Rate to Those Initially Randomized to Rusfertide, with 77.9% Achieving Absence of Phlebotomy Eligibility Between Weeks 40-52Four-Year Results from the Combined REVIVE and Long-Term Extension THRIVE Study Demonstrated a 13-Fold Reduction in Annual Rate of Phlebotomies from Baseline Protagonist Therapeutics, Inc. (“Protagonist”) (NASDAQ:PTGX) and Takeda (TSE:4502/NYSE:TAK) announce that new 52-week results from the pivotal Phase 3 VERIFY study evaluating rusfertide in patients with polycythemia vera (PV) will be presented in an oral presentation at the 67th American Society
Vertex Presents New Data on CASGEVY®, Including First-Ever Data in Children Ages 5-11 Years, at the American Society of Hematology Annual Meeting and Announces Plan for Global Regulatory Submissions6.12.2025 13:01:00 CET | Press release
- Data from pivotal studies of CASGEVY in children ages 5-11 years with severe sickle cell disease or transfusion-dependent beta thalassemia demonstrates the transformative potential of the therapy in younger patients -- Efficacy and safety data in children 5-11 years are consistent with the durable and positive benefit/risk profile established from clinical studies in patients 12 years of age and older -- Vertex expects to initiate global regulatory submissions for CASGEVY in children 5-11 years in 1H 2026 - Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced data from multiple studies demonstrating the clinical benefits of CASGEVY® (exagamglogene autotemcel) in people ages 5 years and older living with severe sickle cell disease (SCD) or transfusion-dependent beta thalassemia (TDT). The results, including the first presentation of clinical data from pivotal studies in children ages 5-11 years, and longer-term data from the pivotal studies of people with severe SCD and
Leading Global Scientists Gather at Tengchong Scientists Forum to Explore Innovative Pathways in Frontier Technologies6.12.2025 12:31:00 CET | Press release
The 2025 Tengchong Scientists Forum opened on Saturday in southwest China’s Yunnan Province, convening leading scientists and academic figures to examine innovation across frontier fields including artificial intelligence, biodiversity and quantum technology. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251205499197/en/ Opening ceremony of Tengchong Scientists Forum on 6th December, 2025 Notable participants include Nobel Physics laureate Konstantin Novoselov, Fields Medalist Efim Zelmanov and Turing Award winner Andrew Chi-Chih Yao, who join 127 academicians, 77 university presidents from China and abroad, over 400 scholars and more than 600 entrepreneurs and financiers. The gathering aims to deepen collaboration between cutting-edge research and industrial development. Under the theme “Science · AI changing the World,” the forum features ten sub-forums, academic sessions and thematic events supporting major cooperation p
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom